Live
- Revanth refutes Modi’s claims on farm loan waiver
- Jupally heads to Las Vegas for Global Investment event
- Govt all set to lay foundation for integrated schools before Dasara
- ARE WE READY FOR WAR ?
- Malabar Gold opens 22nd store in TG
- Free cancer screening for GHMC staff tomorrow
- Three including juvenile arrested for bike theft, 9 bikes recovered
- Zoo celebrates 61st Formation Day
- GHMC norm: Kitchens in hotels to be brought under CCTV lens
- Should temples be free of govt control?
Just In
Misleading ads case: Patanjali tells SC that it has withdrawn sales and advertisements of banned products
Patanjali Ayurved on Tuesday apprised the Supreme Court that it has withdrawn the sale and advertisements of products whose manufacturing licenses were suspended by the Uttarakhand State Licencing Authority in April this year.
New Delhi : Patanjali Ayurved on Tuesday apprised the Supreme Court that it has withdrawn the sale and advertisements of products whose manufacturing licenses were suspended by the Uttarakhand State Licencing Authority in April this year.
A bench, headed by Justice Hima Kohli, was hearing a plea filed by the Indian Medical Association seeking action against Patanjali for violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 – which prohibits the advertisement of certain products for the treatment of specified diseases and disorders, including diabetes, heart diseases, high or low blood pressure and obesity.
Earlier, the top court had questioned senior advocate Balbir Singh, representing Patanjali, about the continued presence of misleading ads, particularly on social media platforms.
In an affidavit filed before the apex court in April this year, the Uttarakhand government said that it has granted permission to file a complaint against Ramdev's Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the drug advertisements law and suspended manufacturing licenses for 14 of their products.
The Supreme Court court had rejected the "unconditional and unqualified apology" tendered by Ramdev and Balkrishna and took strong exception over the violation of the undertaking given to the apex court in November last year.
Patanjali had earlier assured the top court that it would not make any casual statements claiming the medicinal efficacy of its products or advertise or brand them in violation of law and would not release any statement against any system of medicine to the media in any form.
The Supreme Court also took note of the apology issued by Indian Medical Association (IMA) President Dr R.V. Asokan in the IMA's monthly magazine and official website for his statement terming the oral observations made by the apex court during Patanjali misleading advertisements case against allopathy practitioners as "unfortunate" and a "very vague and general statement which has demoralised the doctors".
© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com